Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
The R21/Matrix-M malaria vaccine is a highly effective, low-cost vaccine developed by the University of Oxford and manufactured by the Serum Institute of India. It is the second malaria vaccine recommended and prequalified by the World Health Organization (WHO), offering a crucial tool in reducing childhood mortality in malaria-endemic regions.
The R21/Matrix-M malaria vaccine is a highly effective, low-cost vaccine developed by the University of Oxford and manufactured by the Serum Institute of India. It is the second malaria vaccine recommended and prequalified by the World Health Organization (WHO), offering a crucial tool in reducing childhood mortality in malaria-endemic regions.